Nayak, L., Grommes, C., Kallam, A., Peereboom, D. M., Ambady, P., Mendez, J. S., Aregawi, D. G., Sumrall, A. L., Omuro, A. M. P., Iwamoto, F., Dietrich, J., Umemura, Y., Munker, R., Chukwueke, U. N., Schaff, L., Prados, S., Takazawa, A., Aoi, A., Batchelor, T. (2025). Tirabrutinib for the treatment of relapsed or refractory primary central nervous system lymphoma: Efficacy and safety from the phase II PROSPECT study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2019